Baxter's BioScience Unit Announces Positive Phase III Results for BAX 817

By: via Benzinga
Baxter International Inc. (NYSE: BAX) today announced positive results from its Phase III clinical trial evaluating the safety and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.